Asia Pacific Veterinary Medicine Market Size & Outlook

The veterinary medicine market in Asia Pacific is expected to reach a projected revenue of US$ 26,007.9 million by 2033. A compound annual growth rate of 11% is expected of Asia Pacific veterinary medicine market from 2026 to 2033.
Revenue, 2025 (US$M)
$11,441.6
Forecast, 2033 (US$M)
$26,007.9
CAGR, 2026 - 2033
11%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific veterinary medicine market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific veterinary medicine market highlights

  • The Asia Pacific veterinary medicine market generated a revenue of USD 11,441.6 million in 2025.
  • The market is expected to grow at a CAGR of 11% from 2026 to 2033.
  • In terms of segment, pharmaceuticals was the largest revenue generating product in 2025.
  • Biologics is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2026 to 2033.


Asia Pacific data book summary

Market revenue in 2025USD 11,441.6 million
Market revenue in 2033USD 26,007.9 million
Growth rate11% (CAGR from 2026 to 2033)
Largest segmentPharmaceuticals
Fastest growing segmentBiologics
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationBiologics, Pharmaceuticals, Medicated Feed Additives
Key market players worldwideZoetis Inc Class A, Boehringer Ingelheim, Merck & Co Inc, Elanco Animal Health Inc, Dechra Pharmaceuticals, Ceva Santé Animale, Phibro Animal Health Corp Class A, Virbac SA, Bimeda Ireland, Biogenesis Bago


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 22.2% of the global veterinary medicine market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 26,007.9 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Veterinary Medicine Market Companies

Name Profile # Employees HQ Website
Bimeda Ireland View profile 1001-5000 Tallaght, Dublin, Ireland, Europe https://www.bimeda.ie/
Biogenesis Bago View profile 501-1000 Garín, Buenos Aires, Argentina, South America https://www.biogenesisbago.com/en/
Phibro Animal Health Corp Class A View profile 1920 300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712 https://www.pahc.com
Ceva Santé Animale View profile 5001-10000 Libourne, Aquitaine, France, Europe https://www.ceva.us
Dechra Pharmaceuticals View profile 501-1000 Northwich, Cheshire, United Kingdom, Europe http://www.dechra.com
Boehringer Ingelheim View profile 10001+ Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe https://www.boehringer-ingelheim.com/
Elanco Animal Health Inc View profile 9800 2500 Innovation Way, Greenfield, IN, United States, 46140 https://www.elanco.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Virbac SA View profile 5400 2065m LID, 1 ere avenue, Carros, France, 06516 https://www.virbac.com
Zoetis Inc Class A View profile 14100 10 Sylvan Way, Parsippany, NJ, United States, 07054 https://www.zoetis.com

Asia Pacific veterinary medicine market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary medicine market will help companies and investors design strategic landscapes.


Pharmaceuticals was the largest segment with a revenue share of 63.98% in 2025. Horizon Databook has segmented the Asia Pacific veterinary medicine market based on biologics, pharmaceuticals, medicated feed additives covering the revenue growth of each sub-segment from 2021 to 2033.


The Asia Pacific market is expected to exhibit lucrative growth over the forecast period. This can be attributed to the increasing adoption of pet animals, growing health concerns, increasing vigilance about animal health, rising livestock population, and increasing prevalence of animal diseases.

Moreover, market growth in the region can be attributed to a significantly large cattle population. For instance, China & India constitute more than 30% of the global population of cattle. The large livestock population has enhanced the demand for meat & dairy production, which is expected to further boost the demand for veterinary medicines for livestock animals.

An increase in the number of veterinary hospitals and clinics in countries such as China is further boosting market growth. The region has a wide number of market players. These market players are involved in strategic partnerships, expansions, product launches, and others to cater to market demand.

Reasons to subscribe to Asia Pacific veterinary medicine market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific veterinary medicine market databook

  • Our clientele includes a mix of veterinary medicine market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific veterinary medicine market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific veterinary medicine market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific veterinary medicine market size, by country, 2021-2033 (US$M)

Asia Pacific Veterinary Medicine Market Outlook Share, 2025 & 2033 (US$M)

Asia Pacific veterinary medicine market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online